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ABSTRACT 
Background: Potentially inappropriate medication (PIM) use includes the use of drugs with higher risk where adverse drug effect 
outweighs the clinical benefit, especially when more effective alternative therapy is available. 
Objective: The aim of this study was to assess prevalence and risk factors associated with the use of PIMs in elderly patients at 
medical ward of Ayder Referral Hospital (ARH), Tigray region, Northern Ethiopia.  
Methods: A facility based prospective cross sectional study was conducted among 140 elderly patients from February 6, 2014 to 
May 05, 2014 in ARH. Patients with age ≥ 60 years admitted to medical ward during the study period were randomly selected. Data 
were collected with a structured questionnaire and analyzed using statistical package for social science (SPSS, IBM Corporation) 
version 20. Binary logistic regression was used to analyze factors associated with occurrence of PIM.  
Results: Of 140 patients, 52.1% were males and forty (28.6%) of patients received at least one potentially inappropriate medication. 
The most commonly used potential inappropriate medications were metoclopramide (25.58%), nifedipine (16.28%), diazepam 
(13.95%) and meperedine (13.95%). Above half of (58%) patients encountered polypharmacy. Thirty eight percent of the 
participants’ had comorbid conditions. In the binary logistic analysis, patients with polypharmacy were more likely to receive PIMs 
[AOR 4.163: 95 % CI 1.75– 9.92, p=0.001]. 
Conclusions: Prevalence of PIMs in elderly patients admitted to ARH was high. Polypharmacy was identified as the independent 
predicator of the uses of PIMs. Clinical pharmacists’ are in a position to alert and monitor the exposure to PIMs as part of 
multidisciplinary team. 
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INTRODUCTION 
Ageing is a biological process broadly beyond human 
control and often has its own dynamic. Increasing age 
usually associated with  changes in body composition 
and physiology, may result in the change of  
pharmacokinetics and pharmacodynamics of 
administered drugs 
1,2
. The adulthood of 60 or 65, 
almost correlative to retirement ages in most western 
nations is said to be the starting of old age 
3
. Alongside 
age-related steady changes, the rates for perpetual 
infections and comorbidity increments are trailed by 
constant medication treatment. On the other hand, drug 
treatment in the elders is substantially more difficult and 
complex than in younger adults, particularly because of 
the comorbidity and the expanding number of 
medications for the treatment of diverse conditions
1,4,5
 
Preventable medication related problems are common 
and costly in elders and may lead to poor outcomes. 
PIM use includes the use of drugs with higher risk 
where adverse drug effect outweighs the clinical benefit, 
especially when more effective alternative therapy is 
available 
5,6
. PIMs have been reported as an important 
cause of iatrogenic morbidity, mortality and increased 
healthcare costs 
7,8
. General medication related problems 
among patients with at least one PIM prescription were 
significantly higher than non PIM group with  14.3% 
and 4.7% respectively 
8
. As per Hedna et al., PIMs were 
considered as the cause of 60% of adverse drug 
reactions (ADRs) influencing vascular, half of ADRs 
affecting the nervous system and 62.5% of ADRs 
bringing about falls 
9
. However, the use of PIM is 
common; different studies showed with range between 
34.5- 82.6% of ageing patients were received at least 
one medication with risk outweighs the benefit
10-12
. 
Avoiding the use of inappropriate and high-risk drugs 
may be an important, simple, and effective strategy in 
reducing medication-related problems and adverse drug 
events in older adults. Beer and colleagues developed 
and published explicit list of PIMs for nursing home 
residents in 1991 subsequently expanded and revised in 
1997, 2003 then 2012 to include all settings of geriatric 
care 
6,13-15
 which is important for recognizing and 
avoiding medication with higher risks in seniors to 
improve quality care. However, studies with respect to 
the use of PIMs in Ethiopia are uncommon.  
Therefore, the main aim of this study was to identify the 
prevalence and most commonly used PIMs which will 
be used as a base line data for health service providers for 
promoting rational use of drugs. Furthermore, the purpose 
inlcudes identifying risk factors associated with PIMs in 
elderly patients at medical ward of ARH, Tigray region, 
Northern Ethiopia. Understanding risk factors make 
intervention easy for care givers to targeting factors to 
improve quality of patients care in older adults. 
METHODS AND MATERIALS  
Study area and Period 
The study was conducted from February 6, 2014 to May 
05, 2014 in ARH located in Mekelle, capital city of 
Tigray Region, Northern Ethiopia. ARH is a teaching 
Hospital of Mekelle University and the largest Referral 
Hospital in Tigray Regional State which is located 
783km North of Addis Ababa, capital of Ethiopia. ARH 
commenced rendering its referral and non-referral 
services to the 8 million populations in areas of the 
Tigray, Afar and Southeastern parts of the Amhara 
Regional States. It provides a broad range of medical 
services to both in and out patients of all age groups.  
Study Design and Study Population 
A facility based prospective cross sectional study was 
conducted. To be eligible to participate in the study, 
older adults were required age greater than or equal to 
60 years, admitted to the medical ward, competent to 
give informed consent, at least talking one medication 
and  not critically ill. 
Sample size determination  
The sample size required for the study was determined 
using the formula for estimation of single proportion, 
based on the PIMs proportions of 27%
16
, 5% margin of 
error at 95% confidence level. Total of 322 elderly 
patients were admitted to ARH during the study period 
and finally adjusting for finite population correction a 
sample of 157 patients was taken. Study participants 
were selected employing simple random sampling 
techniques. List of admitted elderly patient at a 
particular time was considered as sampling frame. 
Sampling interval was obtained by dividing the number 
of elderly patients admitted during the study period 
divided by the sample size which gives 2. The first 
patient was selected randomly and every other patient 
was included in the study. 
Data collection methods and tools 
Data were collected using a structured questionnaire and 
the questionnaire included two parts. The first part 
contained questions about the socio-demographic 
characteristics of the patients and diagnosis. The second 
part contained questions related to drug regimens 
prescribed including name, dosages, frequency and 
duration of administration. The questionnaire was 
pretested in 10% of sample size in out of study area in 
Mekelle General Hospital. It was developed in English 
language then translated into local language and data 
were collected by trained graduating class pharmacy 
students. 
Operational definitions 
PIMs refers to any medication listed in updated 2012 
Beers criteria to be avoided in elderly patients 
15
. 
Polypharmacy refers as the use of multiple medications 




2012 Updated Beer's Criteria refers to explicit list of 
medications prepared by American Geriatric Society to 
be avoided in older adults in 2012 because risk 
outweighs benefits 
15
 .  
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Data analysis and management 
First of all, questionnaires were checked for data 
completeness. After that, code was given to each 
questionnaire then data were entered to statistical 
package for social science (SPSS, IBM Corporation) 
version 20 for analysis. Finally, the descriptive statistics 
(frequency, percentage, mean, standard deviation) were 
used to examine the normality of the data and describe 
the analysis. Furthermore, logistic regression with 95% 
confidence interval was done to determine risk factors 
associated with PIMs and P value of less than 0.05 was 
considered statistically significant. 
Ethical clearance 
Ethical clearance was obtained from the Institutional 
Ethics Review Board of the College of Health Sciences, 
Mekelle University(ERC 0362/2014). Study participants 
briefed about the objective of the study with the local 
language (Tigrigna) version and informed consent were 
obtained. The confidentiality and right to refuse 
participation of the study participants were maintained. 
RESULTS 
Total of 157 elderly patients approached 140 patients 
were agreed to participate in the study with response 
rate of 89.2%. The mean age was 68.39 ± 7.26 years and 
male patients represented 52.1% of the study population. 
Patients stayed in the hospital with a mean of 12.51± 
8.99 days while nearly one third (32.9%) of the 
participants had two comorbidities. The sum of the 
number of medication at a time per patient was 814 
drugs, giving an average of 5.81± 3.94. Fifty-nine (40%) 
patients had less than five drugs whereas twenty-five 
(17.9%) patients had nine drugs or more prescribed for 
them (Table 1).   
 
Table 1: Demographic and clinical characterestics of study participants in internal medicine ARH, Tigray region, 
Northern Ethiopia(N=140) 
Characterestics   Frequence (N)  Percentage (%)  
Gender  
 Male  73 52.1 
 Female  67 47.9 
Age (mean ± SD) 68.39 ± 7.26 
 60-69  76 54.3 
 70-79 48 34.3 
 ≥80 16 11.4 
Hospital stay in days (mean ± SD)                             12.51± 8.99 
1-10 73 52.1 
11-20 44 31.4 
≥21 23 16.4 
Prescribed drugs per patient (mean ± SD)                    5.81± 2.98 
 <5 59 42.1 
 5-8 56 40.0 
 ≥9 25 17.9 
 
In this study, Eighty six (61.4 %) patients had at least 
one cardiovascular disease (CVD) or renal disease. 
Heart failure was the common CVD accounting for 22.8 
%, followed by hypertension 20% and 6.4% had both. 
Whereas infectious disease was proved in 58.6 % 
patients, Pneumonia accounted for 32 %, followed by 
Tuberculosis (15 %), urinary tract infection (5.7%) and 
others. The third-ranked class hematological disorder 
diagnosed in 25% of participants, of them anemia 
diagnosed in 13.6 %, pancytopenia in 5% and deep 
venous thrombosis in 3.6 %. Moreover, endocrine 
disorder prevalence was 15% with commonest of 
diabetic mellitus observed in13.6% of study 
participants.   
Reviewing of the prescribed medications using the 2012 
Updated Beer’s Criteria indicated that 40 patients 
received at least one PIM, giving a prevalence rate of 
28.6 %. Forty three PIMs were prescribed to 40 patients 
during this study period. Furthermore, three of patients 
each got 2 PIMs during their stay. The most commonly 
prescribed drug was metoclopramide identified PIMs in 
11(25.58% of all PIM) cases followed by nifedipine 
seven (16.28%) cases while diazepam and meperidine 
were implicated in six (14%) cases each (Table 2).  
Binary logistic regression analysis was performed to 
determine risk factors associated with PIMs. 
Polypharmacy was significantly associated with PIMs 
i.e. patients on polypharmacy were four times more 
likely to have PIMs [AOR, 4.163: 95% CI 1.75 - 9.92 
p=0.001] compared to patients who took less than five 
medications per day. However, age, sex and 
comorbidity had no significant association with 
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Table 2: Prescribed drugs in elderlies that should be avoided based on Beer’s criteria in ARH, Northern Ethiopia, 2015 
Drug name  Frequency Percent (n/T) Potential risk* 
Metoclopramide 11 25.58 Can cause extrapyramidal effects including tardive 
dyskinesia; risk may be even greater in frail older adult. 
Nifedipine 
(immediate release) 
7 16.28 Potential for hypotension; risk of precipitating myocardial 
ischemia. 
Diazepam 6 13.95 Older adults have increased sensitivity to benzodiazepines 
and slower metabolism of long-acting agents. Increase risk 
of cognitive impairment, delirium, falls, fractures, and 
motor vehicle accidents in older adults 
Meperedine  6 13.95 Not an effective oral analgesic in dosages commonly used; 
may cause neurotoxicity. 
Spironolactone > 25 
mg/d for CHF, with 
KCl and ACEI 
5 11.63 The risk of hyperkalemia is higher in older adults 
Sliding scale insulin 3 6.98 Higher risk of hypoglycemia without improvement in 
hyperglycemia management regardless of care setting 
Indomethacin  2 4.65 Increases risk of GI bleeding and  PUD in high-risk groups. 
Amitriptyline   2 4.65 Highly anticholinergic, sedating, and cause orthostatic 
hypotension 
Digoxin > 0.125 mg/d   1 2.32 no additional benefit and may increase risk of toxicity; 
slow renal clearance may lead to risk of toxic effects 
Total  43 100  
*Rationale to avoid in older adults regardless of diseases or conditions, Beers 2012 criteria 
Table 3: Factors associated with potentially inappropriate prescribing in ARH, northern Ethiopia, 2015 
Variable 
 
Category PIM Significance 
(p value) 
Adjust Odds ratio 95% CI for EXP 
No (n) Yes (n)  Lower  Upper  
Age  60-69 52 24     
 70-79 38 10 0.231 0.577 0.235 1.419 
 ≥80 10 6 0.455 1.588 0.472 5.345 
Sex  Male  50 23     
 Female  50 17 0.609 0.812 0.367 1.800 
Comorbidity  No  19 6     
 Yes  81 43 0.613 0.732 0.218 2.457 
Polypharmacy  < 5 drugs 51 8     
 ≥ 5 drugs 49 32 0.001
 
4.163 1.747 9.92 
 
DISCUSSION 
The aim of this study was to estimate prevalence of PIM 
in elderly patients in the ARH which is one of the 
tertiary care settings in the country. We found that more 
than one fourth (28.6%) of the study participants had 
encountered at least one PIM during their hospital stay. 
A systematic review showed that the prevalence of PIM 
using Beer's criteria range from 11.5% to 62.5% 
18
 
where our finding was within this range. Furthermore, 
the result of present study was almost similar to the 
previously conducted study on 1252 patients in North 
Western Ethiopia with a prevalence of 27.7% of PIM 
16
. 
Moreover, this finding was comparable with studies 
done on older patients admitted to six European 
hospitals with overall PIMs prevalence of 30.4% using 
2012 Updated Beer's Criteria, varying from 22.7% in 
Prague to 43.3% in Geneva 
11
. In contrary, some studies 
revealed higher prevalence rate of 49%, 53.6%, and 




 and Croatia 
10
 
respectively. The difference in the prevalence of PIMs 
reported in various studies may be due to the differences 
in patient and disease characteristics, prescribing 




The average number of drugs prescribed per patient in 
this study (5.81) was higher than results from other 





, India (4.3) 
27
 and Brazil (4.4) 
28
. In 
contrary, this finding was lower than studies carried out 
among geriatric patients in USA an average of 8.1 drugs 
per prescription 
29
. This significant difference in the 
number of prescribed drugs for patients in our study 
when compared to developing countries (e.g., Nigeria) 
is the matter of outpatient set up, where participants 
involved. To the opposite developed countries (e.g. 
USA) could be attributed a functional health insurance 
policy for the elderly which may give more access to 
medications. A study done in Indonesia revealed that 24 
% of geriatric institutionalized patients received more 
than five drugs per day during the hospital stay, which 
has exaggerated gap to our study (47.14%) 
30
. This is 
partly due to infectious comorbidity observed besides 
aging related deterioration.  
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Our finding indicated that more than half of the study 
participants 81(57.9 %) used five or more medications at 
times, which is an important factor that was associated 
[AOR= 4.16, 95% CI: 1.75, 9.92] with a stronger 
probability to exposure of PIMs. According to Weng et 
al., there were strong associations between higher PIMs 
with increasing number of medications
31
. Furthermore, a 
study done in China showed that an increased number of 
drugs used was identified as an independent factor 
associated with PIM 
32
. In contrary to this study finding 
some studies showed additional factors associated with 
PIM such as age, sex and hospitalization 
20,33-36
. A meta-
analysis done on determinant factors for the use of PIM 
for the elderly pointed out, there were high degree of 
heterogeneity among the studies and only polypharmacy 
presented a positive association 
37
. This difference 
among studies may be due to selection, stratification of 
the sample and criteria for determining of PIM.  
Four commonly reported inappropriate medications 
which accounts more than two third (69.76%) of all 
encounters where metoclopramide, Nifedipine, 
diazepam and meperidine. Our finding was comparable 
with previous studies done in Ethiopia 
16,38
. According 
to Jhaveri et al., the most common inappropriate 
medications were metoclopramide, alprazolam, 
diazepam, digoxin, and diclofenac 
39
. Moreover, some 
studies showed that almost same group of drugs 
especially benzodiazepines, NSAIDs and antihistamines 
associated with PIM 
26,40,41
. In this study, 
metoclopramide was the most commonly prescribed and 
accounts 25.58% of all PIM which is relatively higher. 
This high rate of prescription may be due to lack of up 
dated knowledge among physicians regarding 
metoclopramide inclusion in new 2012 Updated Beer's 
Criteria. Its use is largely considered inappropriate 




The limitation of this study is cross-sectional outline 
does not permit building up the transience of the 
connection factors. It also does not connect adverse 
reaction reactions outcome due to PIMs use. However, 
one of the strength this study provided was information 
about the most common PIMs. In contrast to previously 
study done in Ethiopia it identifies the factors associated 
with PIMs which helps to overcome the problem.   
CONCLUSION  
In conclusion, nearly one third elderly patients were 
exposed to PIMs during the study period and 
metoclopramide was the most commonly prescribed 
medications. Polypharmacy was identified as the 
independent predicator of the uses of PIMs. Clinical 
pharmacists’ are in a position to alert and monitor the 
exposure to PIMs as part of multidisciplinary team. 
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